Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2005
11/02/2005EP1200123B1 Diagnosis and treatment of neuroectodermal tumors
11/02/2005EP1168923B1 Dna vaccination for treatment of autoimmune disease
11/02/2005EP1067944B1 Combined preparation comprising monocyte derived cells and chemotherapy drugs for the treatment of neoplasic diseases or of infectious diseases
11/02/2005EP1002092B1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/02/2005EP0901521B1 Antigenic modulation of cells
11/02/2005EP0793675B1 Hiv-1- and hiv-2-peptides for inhibition of membrane fusion-associated events, including hiv transmission
11/02/2005CN1692156A Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
11/02/2005CN1692127A TACI antibodies and uses thereof
11/02/2005CN1691964A Epitope sequences
11/02/2005CN1691963A Treatment of tnfalpha related disorders
11/02/2005CN1691962A Improvements of bacterin or related to bacterin
11/02/2005CN1691938A Transdermal vaccine delivery device having coated microprotrusions
11/02/2005CN1689646A Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/02/2005CN1689645A Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/02/2005CN1689644A Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/02/2005CN1225553C Recombinant pseudo-rabies virus expressing swine parvovirus VP gene and vaccine and its preparation method
11/02/2005CN1225480C Anti CD52 monoclonal antibody, coding sequence and use thereof
11/02/2005CN1225479C Tumour necrosis factor antibody, preparing method and medicinal composition thereof
11/02/2005CN1225478C Embedded CD25-resisting monoclonal antibody and its coding sequence and application
11/02/2005CN1225283C Foot-and-mouth disease virus antigen dilution technology
11/01/2005US6961664 Methods of populating data structures for use in evolutionary simulations
11/01/2005US6960652 Used to produce immunotoxins (ITs) and cytokines with a reduced ability to promote vascular leak syndrome (VLS)
11/01/2005US6960570 Compositions and methods for the therapy and diagnosis of lung cancer
11/01/2005US6960569 Hepatitis C virus non-structural NS3/4A fusion gene
11/01/2005US6960469 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
11/01/2005US6960448 Methods for diabetes susceptibility assessment in asymptomatic patients
11/01/2005US6960443 Anticancer, antitumor agents; monoclonal antibodies; genetic engineered protein
11/01/2005US6960351 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
11/01/2005US6960345 Oral vaccinia formulation
11/01/2005US6960344 Use of imine-forming polysaccharides as adjuvants and immunostimulants
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
11/01/2005CA2303526C Hepatitis c virus cell culture system
10/2005
10/29/2005CA2501422A1 Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease
10/28/2005WO2006126981A2 Compositions and methods for mucosal vaccination
10/28/2005CA2564855A1 Compositions and methods for mucosal vaccination
10/27/2005WO2005101021A1 Diagnostics and therapeutics for diseases associated with g protein-coupled adrenergic alpha-1d-receptor (adra1d)
10/27/2005WO2005101017A1 Mass spectrometry of antibody conjugates
10/27/2005WO2005100568A1 Recombined dna, pasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
10/27/2005WO2005100560A1 Cell death inducer
10/27/2005WO2005100558A1 Cd40 ligand mutant and utilization of the same
10/27/2005WO2005100554A1 Novel infectious bursa fabricii's disease virus and vaccine containing the virus
10/27/2005WO2005100547A1 Dendritic cell obtained by antigen pulsing
10/27/2005WO2005100403A2 Antibodies to erythropoietin receptor and uses thereof
10/27/2005WO2005100402A1 Anti-p-selectin antibodies
10/27/2005WO2005100390A2 Bob-1 specific t cells and methods to use
10/27/2005WO2005099776A2 Steroid sparing agents and methods of using same
10/27/2005WO2005099756A2 ErbB ANTAGONISTS FOR PAIN THERAPY
10/27/2005WO2005099755A2 Methods of treating autoimmune and inflammatory diseases
10/27/2005WO2005099754A2 Maytansinoid analogs as antitumor agents
10/27/2005WO2005099753A1 Anti-gluten egg yolk antibodies for the treatment of celiac disease
10/27/2005WO2005099752A2 Antigen delivery vectors and constructs
10/27/2005WO2005099751A2 Apparatus and method for transdermal delivery of influenza vaccine
10/27/2005WO2005099750A1 Vaccination against malignant melanoma using bcg and/or vaccinia
10/27/2005WO2005099744A1 Annexin v for preventing atherothrombois and plaque rupture
10/27/2005WO2005099668A2 Methods of manufacture and use of calcium phosphate particles containing allergens
10/27/2005WO2005073387A3 Method for obtaining precursor z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency
10/27/2005WO2005065707B1 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof
10/27/2005WO2005060642A3 Rationally designed antibodies
10/27/2005WO2005060375A3 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
10/27/2005WO2005040338A3 Constrained alkaloid immunogens and antibodies and uses thereof
10/27/2005WO2005037854A3 Immunogenic peptides
10/27/2005WO2005023299A3 Therapeutic human anti-mhc class ii antibodies and their uses
10/27/2005WO2005009225A3 Tissue adhesive sealant
10/27/2005WO2004101740A3 Clotting factor-fc chimeric proteins to treat hemophilia
10/27/2005WO2004100890A3 Rage g82s-related methods and compositions for treating inflammatory disorders
10/27/2005WO2004065558A3 Depletion of endogenous primordial germ cells in avian species
10/27/2005WO2004055517A3 Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
10/27/2005WO2003072595A3 Methods and products based on oligomerization of stress proteins
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050241024 Transgenic plant-based vaccines
10/27/2005US20050240012 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity
10/27/2005US20050240009 T-cell epitopes in staphylococcal enterotoxin b
10/27/2005US20050240006 Cytoplasmic region with more than 107 or less than 104 amino acids, a transmembrance region, and an extracellular region; nucleic acids and antibodies; diagnosing hematopoietic cell malignancy or autoimmune disease
10/27/2005US20050239815 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor
10/27/2005US20050239736 Composition for treating an immune system deficiency comprising vaccine and an oligonucleotide delivery complex having an immunostimulatory dinucleotide associated with lipid or sterol; antisense therapies; gene expression inhibition; viricides
10/27/2005US20050239734 C-class oligonucleotide analogs with enhanced immunostimulatory potency
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
10/27/2005US20050239730 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
10/27/2005US20050239729 Incorporating the pro-apoptotic protein BAX and autoantigens adenoviral protein E3-GP19k and Delta BCL-2 into an injectable antidiabetic or hypoglycemic formulation; prevention, diagnosis and monitoring of diabetic patients
10/27/2005US20050239701 Transient and/or permanent modification of sexual behavior and/or fertility using recombinant chimeric GnRH
10/27/2005US20050239700 Treatment of cancer using antibodies to LRRC15
10/27/2005US20050239169 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/27/2005US20050239167 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/27/2005US20050239163 Cloning, expression and functional characterization of a mammalian DNA-R gene; polypetide having amino acid sequence with deletion at 1133 1171 amino acids
10/27/2005US20050239160 Method for identification of proteins from intracellular bacteria
10/27/2005US20050239147 Exposing a test sample from an animal, e.g., bovine, to a population of microorganisms, especially killed Mycobacterium avium subsp. paratuberculosis, and determining if the test sample contains an antibody that binds to the microorganism, preferably to the surface of the microorganism
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/27/2005US20050239064 Methods and compositions based on protein interactions with mastermind
10/27/2005US20050239056 Methods and kits for predicting an infectious disease state
10/27/2005US20050239052 Cloning of rhadinovirus genome and methods for its use
10/27/2005US20050238689 Bioactive stents for type II diabetics and methods for use thereof
10/27/2005US20050238671 Superantigen enhancement of specific immune responses
10/27/2005US20050238669 Animal product free system and process for purifying a botulinum toxin
10/27/2005US20050238668 Media for clostridium bacterium and processes for obtaining a clostridial toxin
10/27/2005US20050238666 Methods of enhancing stem cell engraftment
10/27/2005US20050238665 Soluble recombinant botulinum toxin proteins
10/27/2005US20050238662 Immunogens; water-in-oil emulsions; oil-in-water emulsions; vaccines; freeze drying
10/27/2005US20050238661 Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
10/27/2005US20050238660 Cpg formulations and related methods
1 ... 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 ... 1823